MUST READ Interview with Jane Axelrad, CDER's associate director for policy---FDA News FDA to Partner with States on Compounding Oversight

Jane Axelrad, CDER’s associate director for policy, spoke with Drug Daily Bulletin to discuss the FDA’s strategy for regulating compounding pharmacies following the recent passage of the Drug Quality and Security Act.

FDAnews: What is the greatest challenge the FDA faces as it sets out to regulate the compounding industry with its new authorities?

 continue to read here